{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:46:07Z","timestamp":1790721967604,"version":"4.1.0"},"reference-count":114,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.beha.2009.05.001","type":"journal-article","created":{"date-parts":[[2009,8,20]],"date-time":"2009-08-20T08:16:41Z","timestamp":1250756201000},"page":"191-210","source":"Crossref","is-referenced-by-count":36,"title":["Gene expression profiling in lymphoma diagnosis and management"],"prefix":"10.1016","volume":"22","author":[{"given":"Javeed","family":"Iqbal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZhongFeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Deffenbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing C.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beha.2009.05.001_bib1","series-title":"Tumors of the hematopoietic system. Atlas of tumour pathlogy","author":"Rappaport","year":"1966"},{"issue":"4 Suppl","key":"10.1016\/j.beha.2009.05.001_bib2","article-title":"Immunologic characterization of human malignant lymphomas","volume":"34","author":"Lukes","year":"1974","journal-title":"Cancer"},{"issue":"8580","key":"10.1016\/j.beha.2009.05.001_bib3","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(88)90367-4","article-title":"Updated Kiel classification for lymphomas","volume":"1","author":"Stansfeld","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.beha.2009.05.001_bib4","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2","article-title":"National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage","volume":"49","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/j.beha.2009.05.001_bib5","series-title":"WHO classification: pathology and genetics of tumors of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2008"},{"issue":"6","key":"10.1016\/j.beha.2009.05.001_bib6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1046\/j.1365-2796.1998.00343.x","article-title":"The genetic analysis of cancer","volume":"243","author":"Pearson","year":"1998","journal-title":"J Intern Med"},{"key":"10.1016\/j.beha.2009.05.001_bib7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1749-6632.1997.tb48593.x","article-title":"Hereditary predisposition to cancer","volume":"833","author":"Knudson","year":"1997","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.beha.2009.05.001_bib8","first-page":"829","article-title":"Fundamentals of DNA-chip\/array technology for comparative gene-expression analysis","volume":"83","author":"Saluz","year":"2002","journal-title":"Curr Sci"},{"issue":"2","key":"10.1016\/j.beha.2009.05.001_bib9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0952-7915(99)00074-6","article-title":"Analysis of large-scale gene expression data","volume":"12","author":"Sherlock","year":"2000","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"10.1016\/j.beha.2009.05.001_bib11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.copbio.2007.10.008","article-title":"Microarray-based expression profiling and informatics","volume":"19","author":"Simon","year":"2008","journal-title":"Curr Opin Biotechnol"},{"issue":"9","key":"10.1016\/j.beha.2009.05.001_bib12","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/nbt1239","article-title":"The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements","volume":"24","author":"Shi","year":"2006","journal-title":"Nat Biotechnol"},{"issue":"10","key":"10.1016\/j.beha.2009.05.001_bib13","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/nbt1486","article-title":"Next-generation DNA sequencing","volume":"26","author":"Shendure","year":"2008","journal-title":"Nat Biotechnol"},{"issue":"6769","key":"10.1016\/j.beha.2009.05.001_bib14","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"issue":"25","key":"10.1016\/j.beha.2009.05.001_bib15","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.beha.2009.05.001_bib16","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","article-title":"Stromal gene signatures in large-B-cell lymphomas","volume":"359","author":"Lenz","year":"2008","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.beha.2009.05.001_bib17","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1182\/blood-2004-07-2947","article-title":"Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response","volume":"105","author":"Monti","year":"2005","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.beha.2009.05.001_bib18","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1084\/jem.20031074","article-title":"Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma","volume":"198","author":"Rosenwald","year":"2003","journal-title":"J Exp Med"},{"issue":"12","key":"10.1016\/j.beha.2009.05.001_bib19","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1182\/blood-2003-06-1841","article-title":"The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma","volume":"102","author":"Savage","year":"2003","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.beha.2009.05.001_bib20","first-page":"529","article-title":"Differential expression of chemokines, chemokine receptors, cytokines and cytokine receptors in diffuse large B cell malignant lymphoma","volume":"24","author":"Fujii","year":"2004","journal-title":"Int J Oncol"},{"issue":"9","key":"10.1016\/j.beha.2009.05.001_bib21","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1182\/blood-2004-04-1594","article-title":"Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling","volume":"105","author":"Hoefnagel","year":"2005","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.beha.2009.05.001_bib22","first-page":"60","article-title":"Microarray reveals differences in both tumors and vascular specific gene expression in de novo CD5+ and CD5- diffuse large B-cell lymphomas","volume":"63","author":"Kobayashi","year":"2003","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/j.beha.2009.05.001_bib23","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1182\/blood-2002-10-3090","article-title":"Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts","volume":"101","author":"Klein","year":"2003","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.beha.2009.05.001_bib24","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1128\/JVI.79.2.1244-1251.2005","article-title":"Distinct subsets of primary effusion lymphoma can be identified based on their cellular gene expression profile and viral association","volume":"79","author":"Fan","year":"2005","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.beha.2009.05.001_bib25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1535-6108(03)00028-X","article-title":"The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma","volume":"3","author":"Rosenwald","year":"2003","journal-title":"Cancer Cell"},{"issue":"13","key":"10.1016\/j.beha.2009.05.001_bib26","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1182\/blood-2005-04-1753","article-title":"Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling","volume":"106","author":"Fu","year":"2005","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.beha.2009.05.001_bib27","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1182\/blood-2007-10-118794","article-title":"Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas","volume":"111","author":"Wlodarska","year":"2008","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.beha.2009.05.001_bib28","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa041869","article-title":"Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells","volume":"351","author":"Dave","year":"2004","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.beha.2009.05.001_bib29","doi-asserted-by":"crossref","first-page":"7180","DOI":"10.1158\/1078-0432.CCR-08-0752","article-title":"Clonal evolution in t(14;18)-positive follicular lymphoma, evidence for multiple common pathways, and frequent parallel clonal evolution","volume":"14","author":"d'Amore","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.beha.2009.05.001_bib30","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1182\/blood.V80.3.758.758","article-title":"MYC rearrangements in histologically progressed follicular lymphomas","volume":"80","author":"Yano","year":"1992","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.beha.2009.05.001_bib31","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1182\/blood.V82.7.1994.1994","article-title":"p53 mutation is associated with progression in follicular lymphomas","volume":"82","author":"Sander","year":"1993","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.beha.2009.05.001_bib32","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1182\/blood.V88.10.3937.bloodjournal88103937","article-title":"Morphologic transformation of follicular lymphoma is associated with somatic mutation of the translocated Bcl-2 gene","volume":"88","author":"Matolcsy","year":"1996","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.beha.2009.05.001_bib33","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1182\/blood.V91.12.4677","article-title":"Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histologic progression in follicle center lymphoma","volume":"91","author":"Elenitoba-Johnson","year":"1998","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.beha.2009.05.001_bib34","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1182\/blood.V91.8.2977.2977_2977_2984","article-title":"p16 (INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas","volume":"91","author":"Pinyol","year":"1998","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.beha.2009.05.001_bib35","doi-asserted-by":"crossref","first-page":"8886","DOI":"10.1073\/pnas.132253599","article-title":"Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes","volume":"99","author":"Lossos","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.beha.2009.05.001_bib36","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1182\/blood-2002-07-2119","article-title":"Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations","volume":"101","author":"Martinez-Climent","year":"2003","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.beha.2009.05.001_bib37","doi-asserted-by":"crossref","first-page":"7259","DOI":"10.1073\/pnas.1137463100","article-title":"Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy","volume":"100","author":"Elenitoba-Johnson","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.beha.2009.05.001_bib38","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1182\/blood-2003-06-2160","article-title":"Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosis","volume":"103","author":"Thieblemont","year":"2004","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.beha.2009.05.001_bib39","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project","volume":"89","year":"1997","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.beha.2009.05.001_bib40","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/annonc\/mdf033","article-title":"Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project","volume":"13","author":"Rudiger","year":"2002","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.beha.2009.05.001_bib41","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1080\/10428190290016926","article-title":"T-cell non-Hodgkin's lymphoma in adults: clinicopathological characteristics, response to treatment and prognostic factors","volume":"43","author":"Reiser","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.beha.2009.05.001_bib42","doi-asserted-by":"crossref","first-page":"811a","DOI":"10.1182\/blood.V106.11.811.811","article-title":"International Peripheral T-cell Lymphoma (PTCL) Clinical and Pathology Review project: poor outcome by prognostic indices and lack of efficacy with anthracyclines","volume":"106","author":"Vose","year":"2005","journal-title":"Blood"},{"issue":"25","key":"10.1016\/j.beha.2009.05.001_bib43","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/t-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"10.1016\/j.beha.2009.05.001_bib44","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1182\/blood-2006-10-055145","article-title":"The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells","volume":"109","author":"de Leval","year":"2007","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.beha.2009.05.001_bib45","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/hon.781","article-title":"Peripheral T-cell lymphoma gene expression profiles","volume":"24","author":"Martinez-Delgado","year":"2006","journal-title":"Hematol Oncol"},{"issue":"22","key":"10.1016\/j.beha.2009.05.001_bib46","doi-asserted-by":"crossref","first-page":"10703","DOI":"10.1158\/0008-5472.CAN-07-1708","article-title":"Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation","volume":"67","author":"Piccaluga","year":"2007","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.beha.2009.05.001_bib47","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1172\/JCI26833","article-title":"Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets","volume":"117","author":"Piccaluga","year":"2007","journal-title":"J Clin Invest"},{"issue":"7167","key":"10.1016\/j.beha.2009.05.001_bib48","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nature06253","article-title":"Roquin represses autoimmunity by limiting inducible T-cell co-stimulator messenger RNA","volume":"450","author":"Yu","year":"2007","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.beha.2009.05.001_bib49","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1182\/blood.V79.7.1789.1789","article-title":"Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma","volume":"79","author":"Weiss","year":"1992","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.beha.2009.05.001_bib50","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1182\/blood-2006-03-006403","article-title":"Tolerogenic dendritic cells: cytokine modulation comes of age","volume":"108","author":"Rutella","year":"2006","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.beha.2009.05.001_bib51","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.4049\/jimmunol.164.7.3596","article-title":"Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation","volume":"164","author":"Hwu","year":"2000","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.beha.2009.05.001_bib52","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0092-8674(93)80068-P","article-title":"Interleukin-10-deficient mice develop chronic enterocolitis","volume":"75","author":"Kuhn","year":"1993","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.beha.2009.05.001_bib53","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.coi.2007.04.014","article-title":"New twists of T cell fate: control of T cell activation and tolerance by TGF-beta and NFAT","volume":"19","author":"Sundrud","year":"2007","journal-title":"Curr Opin Immunol"},{"issue":"4","key":"10.1016\/j.beha.2009.05.001_bib54","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/00000478-200604000-00009","article-title":"Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL): a new diagnostic marker providing evidence that AITL derives from follicular helper T cells","volume":"30","author":"Dupuis","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.beha.2009.05.001_bib55","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1038\/sj.leu.2403960","article-title":"Differential expression of NF-kappaB pathway genes among peripheral T-cell lymphomas","volume":"19","author":"Martinez-Delgado","year":"2005","journal-title":"Leukemia"},{"issue":"5151","key":"10.1016\/j.beha.2009.05.001_bib56","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1126\/science.8122112","article-title":"Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma","volume":"263","author":"Morris","year":"1994","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.beha.2009.05.001_bib57","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2141.1989.tb06270.x","article-title":"A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma (\u2018Ki-1 lymphoma\u2019)","volume":"71","author":"Rimokh","year":"1989","journal-title":"Br J Haematol"},{"issue":"5196","key":"10.1016\/j.beha.2009.05.001_bib58","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1126\/science.7824924","article-title":"Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma","volume":"267","author":"Morris","year":"1995","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.beha.2009.05.001_bib59","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1365-2141.2001.02574.x","article-title":"Alk+ CD30+ lymphomas: a distinct molecular genetic subtype of non-Hodgkin's lymphoma","volume":"113","author":"Morris","year":"2001","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.beha.2009.05.001_bib60","first-page":"2194","article-title":"Role of phosphatidylinositol 3-kinase-Akt pathway in nucleophosmin\/anaplastic lymphoma kinase-mediated lymphomagenesis","volume":"61","author":"Slupianek","year":"2001","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.beha.2009.05.001_bib61","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/nm1659","article-title":"STAT5A is epigenetically silenced by the tyrosine kinase NPM1-ALK and acts as a tumor suppressor by reciprocally inhibiting NPM1-ALK expression","volume":"13","author":"Zhang","year":"2007","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.beha.2009.05.001_bib62","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1172\/JCI29401","article-title":"Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes","volume":"116","author":"Piva","year":"2006","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.beha.2009.05.001_bib63","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.leukres.2007.07.012","article-title":"Analysis of gene expression profile of TPM3-ALK positive anaplastic large cell lymphoma reveals overlapping and unique patterns with that of NPM-ALK positive anaplastic large cell lymphoma","volume":"32","author":"Bohling","year":"2008","journal-title":"Leuk Res"},{"issue":"2","key":"10.1016\/j.beha.2009.05.001_bib64","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1089\/152581602753658619","article-title":"Gene profiling in anaplastic large-cell lymphoma-derived cell lines with cDNA expression arrays","volume":"11","author":"Gaiser","year":"2002","journal-title":"J Hematother Stem Cell Res"},{"issue":"10","key":"10.1016\/j.beha.2009.05.001_bib65","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1182\/blood.V88.10.4005.bloodjournal88104005","article-title":"Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules","volume":"88","author":"Foss","year":"1996","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.beha.2009.05.001_bib66","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1182\/blood-2004-03-1037","article-title":"Anaplastic large cell lymphomas lack the expression of T-cell receptor molecules or molecules of proximal T-cell receptor signaling","volume":"104","author":"Bonzheim","year":"2004","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.beha.2009.05.001_bib67","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1365-2141.2007.06924.x","article-title":"Genomic profiling reveals different genetic aberrations in systemic ALK-positive and ALK-negative anaplastic large cell lymphomas","volume":"140","author":"Salaverria","year":"2008","journal-title":"Br J Haematol"},{"issue":"39","key":"10.1016\/j.beha.2009.05.001_bib68","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1038\/sj.onc.1208968","article-title":"Global epidemiology of HTLV-I infection and associated diseases","volume":"24","author":"Proietti","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.beha.2009.05.001_bib69","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0065-230X(03)01003-0","article-title":"Seizing of T cells by human T-cell leukemia\/lymphoma virus type 1","volume":"89","author":"Franchini","year":"2003","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.beha.2009.05.001_bib70","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1742-4690-1-20","article-title":"Role of Tax protein in human T-cell leukemia virus type-I leukemogenicity","volume":"1","author":"Azran","year":"2004","journal-title":"Retrovirology"},{"issue":"33","key":"10.1016\/j.beha.2009.05.001_bib71","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1038\/sj.onc.1206549","article-title":"Cellular transformation by the HTLV-I Tax protein, a jack-of-all-trades","volume":"22","author":"Gatza","year":"2003","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.beha.2009.05.001_bib72","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1182\/blood-2004-03-1222","article-title":"Overexpression of a cell adhesion molecule, TSLC1, as a possible molecular marker for acute-type adult T-cell leukemia","volume":"105","author":"Sasaki","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.beha.2009.05.001_bib73","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2008-08-175901","article-title":"Gene expression profiling of ATL patients: compilation of disease related genes and evidence for TCF-4 involvement in BIRC5 gene expression and cell viability","author":"Pise-Masison","year":"2009","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.beha.2009.05.001_bib74","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/sj.onc.1209178","article-title":"Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas","volume":"25","author":"Ballester","year":"2006","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.beha.2009.05.001_bib75","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2141.2008.07042.x","article-title":"Cytogenetic abnormalities and clinical correlations in peripheral T-cell lymphoma","volume":"141","author":"Nelson","year":"2008","journal-title":"Br J Haematol"},{"issue":"22","key":"10.1016\/j.beha.2009.05.001_bib76","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1200\/JCO.2006.09.4474","article-title":"Identification of a proliferation signature related to survival in nodal peripheral T-cell lymphomas","volume":"25","author":"Cuadros","year":"2007","journal-title":"J Clin Oncol"},{"issue":"21","key":"10.1016\/j.beha.2009.05.001_bib77","doi-asserted-by":"crossref","first-page":"6284","DOI":"10.1158\/1078-0432.CCR-07-0525","article-title":"Gene expression profiling from formalin-fixed paraffin-embedded tumors of pediatric glioblastoma","volume":"13","author":"Haque","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.beha.2009.05.001_bib78","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1182\/blood-2008-02-130435","article-title":"Whole genome scanning as a cytogenetic tool in hematologic malignancies","volume":"112","author":"Maciejewski","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.beha.2009.05.001_bib79","first-page":"41","article-title":"Comparative genomic hybridization: a rapid new method for detecting and mapping DNA amplification in tumors","volume":"4","author":"Kallioniemi","year":"1993","journal-title":"Semin Cancer Biol"},{"issue":"37 Suppl","key":"10.1016\/j.beha.2009.05.001_bib80","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1038\/ng1569","article-title":"Array comparative genomic hybridization and its applications in cancer","author":"Pinkel","year":"2005","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.beha.2009.05.001_bib81","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/ng1307","article-title":"A tiling resolution DNA microarray with complete coverage of the human genome","volume":"36","author":"Ishkanian","year":"2004","journal-title":"Nat Genet"},{"key":"10.1016\/j.beha.2009.05.001_bib82","unstructured":"Affymetrix I. High-resolution chromosome copy number analysis using GeneChip mapping arrays. Affymetrix Product Family GeneChip Chromosome Copy Number Analysis Tool 2005."},{"issue":"29","key":"10.1016\/j.beha.2009.05.001_bib83","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1038\/sj.onc.1210190","article-title":"Genome complexity in acute lymphoblastic leukemia is revealed by array-based comparative genomic hybridization","volume":"26","author":"Strefford","year":"2007","journal-title":"Oncogene"},{"issue":"36","key":"10.1016\/j.beha.2009.05.001_bib84","doi-asserted-by":"crossref","first-page":"13520","DOI":"10.1073\/pnas.0804295105","article-title":"Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways","volume":"105","author":"Lenz","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.beha.2009.05.001_bib85","doi-asserted-by":"crossref","unstructured":"Iqbal J, Can Kucuk, DeLeeuw RJ, et\u00a0al. Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies. Leukemia, in press [online publication 5 February 2009, doi:10.1038\/leu.2009.3].","DOI":"10.1038\/leu.2009.3"},{"issue":"1","key":"10.1016\/j.beha.2009.05.001_bib86","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cell.2007.12.024","article-title":"Getting to the root of miRNA-mediated gene silencing","volume":"132","author":"Eulalio","year":"2008","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.beha.2009.05.001_bib87","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/MOH.0b013e328303e15d","article-title":"MicroRNAs in normal and malignant hematopoiesis","volume":"15","author":"Garzon","year":"2008","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.beha.2009.05.001_bib88","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V112.11.805.805","article-title":"Differentiation-stage-specific expression of microRNAs in B-lymphocytes and diffuse large B-cell lymphomas","author":"Malumbres","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.beha.2009.05.001_bib89","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2008-09-178186","article-title":"Patterns of microRNA expression characterize stages of human B cell differentiation","author":"Zhang","year":"2009","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.beha.2009.05.001_bib90","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1038\/sj.leu.2405083","article-title":"MicroRNA expression in lymphocyte development and malignancy","volume":"22","author":"Lawrie","year":"2008","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.beha.2009.05.001_bib91","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1073\/pnas.0307323101","article-title":"Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers","volume":"101","author":"Calin","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.beha.2009.05.001_bib92","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1128\/MCB.17.3.1490","article-title":"bic, a novel gene activated by proviral insertions in avian leukosis virus-induced lymphomas, is likely to function through its noncoding RNA","volume":"17","author":"Tam","year":"1997","journal-title":"Mol Cell Biol"},{"issue":"10","key":"10.1016\/j.beha.2009.05.001_bib93","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1073\/pnas.0500613102","article-title":"Accumulation of miR-155 and BIC RNA in human B cell lymphomas","volume":"102","author":"Eis","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.beha.2009.05.001_bib94","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/gcc.20273","article-title":"Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma","volume":"45","author":"Kluiver","year":"2006","journal-title":"Genes Chromosomes Cancer"},{"issue":"17","key":"10.1016\/j.beha.2009.05.001_bib95","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa050995","article-title":"A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia","volume":"353","author":"Calin","year":"2005","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.beha.2009.05.001_bib96","doi-asserted-by":"crossref","first-page":"11816","DOI":"10.1073\/pnas.95.20.11816","article-title":"BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci","volume":"95","author":"Pasqualucci","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"10.1016\/j.beha.2009.05.001_bib97","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1182\/blood-2007-02-072082","article-title":"Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor-2, predict for poor survival in diffuse large B-cell lymphoma","volume":"110","author":"Young","year":"2007","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.beha.2009.05.001_bib98","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1182\/blood-2005-09-3778","article-title":"Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas","volume":"107","author":"Tam","year":"2006","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.beha.2009.05.001_bib99","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1084\/jem.20052204","article-title":"Inactivation of the PRDM1\/BLIMP1 gene in diffuse large B cell lymphoma","volume":"203","author":"Pasqualucci","year":"2006","journal-title":"J Exp Med"},{"issue":"5870","key":"10.1016\/j.beha.2009.05.001_bib100","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1126\/science.1153629","article-title":"Oncogenic CARD11 mutations in human diffuse large B cell lymphoma","volume":"319","author":"Lenz","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.beha.2009.05.001_bib101","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2008-08-174110","article-title":"The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone B-cell lymphomas","author":"Novak","year":"2009","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.beha.2009.05.001_bib102","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/8767","article-title":"Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14) (p22;q32)","volume":"22","author":"Zhang","year":"1999","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.beha.2009.05.001_bib103","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.tig.2007.12.007","article-title":"The impact of next-generation sequencing technology on genetics","volume":"24","author":"Mardis","year":"2008","journal-title":"Trends Genet"},{"issue":"11","key":"10.1016\/j.beha.2009.05.001_bib104","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1182\/blood-2008-04-152900","article-title":"New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic and transcriptional profiling","volume":"113","author":"Martin-Subero","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.beha.2009.05.001_bib105","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/3-540-31181-5_12","article-title":"Cancer-linked DNA hypomethylation and its relationship to hypermethylation","volume":"310","author":"Ehrlich","year":"2006","journal-title":"Curr Top Microbiol Immunol"},{"issue":"1","key":"10.1016\/j.beha.2009.05.001_bib106","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2007.06604.x","article-title":"Gene silencing by DNA methylation in haematological malignancies","volume":"138","author":"Boultwood","year":"2007","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.beha.2009.05.001_bib107","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/leu.2008.18","article-title":"DNA methylation profiles in diffuse large B-cell lymphoma and their relationship to gene expression status","volume":"22","author":"Pike","year":"2008","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.beha.2009.05.001_bib108","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1084\/jem.194.12.1861","article-title":"Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells","volume":"194","author":"Davis","year":"2001","journal-title":"J Exp Med"},{"issue":"7074","key":"10.1016\/j.beha.2009.05.001_bib109","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nature04296","article-title":"Oncogenic pathway signatures in human cancers as a guide to targeted therapies","volume":"439","author":"Bild","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.beha.2009.05.001_bib110","article-title":"A peptomimetic inhibitor of BCL6 with potent anti-lymphoma effects in vitro and in vivo","author":"Cerchietti","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.beha.2009.05.001_bib111","first-page":"108a","article-title":"Phase II study of proteasome inhibitor Bortezomib (Velcade\u00ae) in patients with relapsed\/refractory T-cell lymphoma: preliminary results","author":"Zinzani","year":"2006","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.beha.2009.05.001_bib112","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S1470-2045(05)70213-8","article-title":"Expression of platelet-derived growth factor receptor alpha in peripheral T-cell lymphoma not otherwise specified","volume":"6","author":"Piccaluga","year":"2005","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.beha.2009.05.001_bib113","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.1182\/blood-2008-02-136374","article-title":"Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP","volume":"111","author":"Malumbres","year":"2008","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.beha.2009.05.001_bib114","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/labinvest.3700665","article-title":"Quantitative nuclease protection assay in paraffin-embedded tissue replicates prognostic microarray gene expression in diffuse large-B-cell lymphoma","volume":"87","author":"Roberts","year":"2007","journal-title":"Lab Invest"},{"issue":"1","key":"10.1016\/j.beha.2009.05.001_bib115","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692609000279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692609000279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T15:35:48Z","timestamp":1590075348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692609000279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":114,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S1521692609000279"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2009.05.001","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}